Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Non-GAAP Adjusted Income Attributable to Pfizer Common by Quarter
Non-GAAP Adjusted Income Attributable to Pfizer Common Shareholders ($M) ($M)
Pfizer Non-GAAP Adjusted Income Attributable to Pfizer Common: $4,440M in Q2 2026, up 0.1% from a year earlier.
Where the Q2 2026 figure comes from
“|| Adjusted (3) Income | 4,440 | 4,434 | —% | 8,730 | 9,671 | (10%)”
Source: Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗
Reported in Form 8-K Non-GAAP Reconciliation Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-GAAP Adjusted Income Attributable to Pfizer Common
Cite this data
StockData. (2026). Pfizer Non-GAAP Adjusted Income Attributable to Pfizer Common ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/adj-income
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.